Clinical Study to Investigate the Safety and Efficacy of MLC601 in 150 Iranian Patients After Stroke

• Status: Completed
• Trial end date: 2010-12-01
• Target enrollment: 0
• Participant gender: All

Summary

To investigate the safety and efficacy of MLC601 (NeuroAideTM) as a Traditional Chinese Medicine on motor recovery after ischemic stroke.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shahid Beheshti University
• Collaborator: Shahid Beheshti University of Medical Sciences

Criteria

Inclusion Criteria:

• age between 30-72 yars,

• < one month after stroke,

• ischemic cerebral stroke,

• signed informed consent form.

Exclusion Criteria:

• treatment with thrombolytic after stoke,

• ischemic stroke combined with hemorrhage, severe renal or liver failure, dementia, psychosis and history of seizure disorder, history of previous stroke, and hemoglobin level less than 10mg/dl on admission.